IL37 and skin sarcoidosis: Recently, monoclonal antibodies inhibiting interleukin 12, interleukin 23, and tumor necrosis factor alpha have been tested in patients with lung and/or skin sarcoidosis, however, the superiority of this treatment compared with steroids is unclear [22].